Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy (Pregnancy)
REBIRTH - Study of Bromocriptine in Women with Peripartum Cardiomyopathy (PPCM)
Sponsor: NIH
Enrolling: Female Patients Only
IRB Number: AAAU2889
U.S. Govt. ID: NCT05180773
Contact: Jennifer Haythe: / jhh28@cumc.columbia.edu
Additional Study Information: We are doing this study to test the use of a drug called bromocriptine for women with a condition called Peripartum cardiomyopathy (PPCM). The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.
Jennifer Haythe, MD
Do You Qualify?
Have you been diagnosed with peripartum cardiomyopathy? Yes No
Are you in the last month of your pregnancy or the first 5 months postpartum? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Jennifer Haythe